Test cancer patients for clot susceptibility, group recommends

06/5/2013 | MedPage Today (free registration)

Cancer patients should be regularly tested for thromboembolic risk upon starting chemotherapy, according to guidelines from the American Society of Clinical Oncology that are published in the Journal of Clinical Oncology. The group recommended low-molecular-weight heparin for prophylaxis. Newer oral anticoagulants should not be administered in patients with malignancy.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Fort Worth, TX